Because an excessive oxidative stress response can lead to cell death (103) and the nuclear lamina can protect against ROS (73), these data suggest that the claudin-4’s role in remodeling the nuclear architecture (Figs. 3 and 4) may help protect tumor cells during excessive oxidative stress response during olaparib treatment. Here, CLDN4 is linked to neoplasm.